funder-graph

FundersCTAlliance for Cancer Gene Therapy Inc › 2023

Grants paid by Alliance for Cancer Gene Therapy Inc, tax year 2023

EIN 06-1619523 · Stamford, CT · Form 990, Schedule I · NTEE T30

In tax year 2023, Alliance for Cancer Gene Therapy Inc (EIN 06-1619523) reported 6 grants paid totaling $1,735,341. Dataset version 2026.09.0, built 2026-09-03.

20212022202320242025

Every grant, 2023

Grants reported by Alliance for Cancer Gene Therapy Inc for tax year 2023
Tax yearRecipientMatchAmountTypePurposeSource filing
2023Pci New York, NYA$750,000paidCANCER RESEARCH202400229349301350
2023Okada Univ of Ca Sanfransico, CAA$492,904paidCANCER RESEARCH202400229349301350
2023Fueyo Univ of Texas Houston, TXA$480,024paidCANCER RESEARCH202400229349301350
2023Zureikat Univ Pitts Pittsburgh, PAA$12,057paidCANCER RESEARCH202400229349301350
2023Brownicahn School New York, NYA$213paidCANCER RESEARCH202400229349301350
2023Chen Yale Univ New Haven, CTA$143paidCANCER RESEARCH202400229349301350

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.